Hon. Mike Farhat is Chairman of United States Global Partners and is a prolific and respected business leader, humanitarian and philanthropist

Presided over billions of dollars in development and trade projects in multiple industries globally, including medical and healthcare, hospitality, banking, aviation, public safety, finance and large-scale public-private sector development projects

Contributed and provided Board service to many charitable foundations and projects, including Sania Care Foundation (Chairman), National Charity League, GRACE, Kids Matter International, Texas Student Housing, NLF Education Foundation, Harris Hospital Health Exchange and the Dallas U.S. Olympic Committee

Pursues his strong passion for helping thousands across the world rise above their circumstances by supporting families and communities in need

Hon. Farhat has been named Honorary Texan and Businessman of the Year

Holds a Baccalaureate degree in International Business from Lecole de Al Adab University

A proven and effective strategic leader, serial entrepreneur and business builder with over 30 years of extensive experience assisting companies in complex transactions

Founded and grew KBA Group, LLP into the largest Dallas based CPA and Advisory firm with a diversified menu of services and led the firm’s strategic growth, both organic and through acquisition. Initiated and constructed the firm’s merger with the tenth largest national CPA firm, and served as the Dallas office Managing Partner post-merger

Assisted numerous clients with business strategy, transactions including IPOs, reverse mergers, Special Purpose Acquisition Companies, and mergers and acquisitions from both the buy side and sell side

Larry has worked with both domestic and international companies in numerous industries including manufacturing and distribution, technology, software, services, energy, logistics, healthcare, real estate and retail

Achievements include the Texas Society of CPAs Lone Star Pathfinder Award; Practical Accountant Practice Innovation Award; Journal of Accountancy Feature Article (regarding Sarbanes-Oxley Compliance) and others

CPA, CGMA, BS Accounting and Operations Research graduating (graduating Beta Gamma), Babson College, Wellesley, Mass.

Proven leader with demonstrated success in the medical device industry. Skilled in Market Development, Commercialization, Strategy, Product Development, Clinical Research, Quality and Manufacturing

Career highlights spanning over 35 years include: 9 years at Neuromodulation Division at St. Jude Medical, culminating in President role; COO at Cyberonics/President Neuromodulation LivaNova, 10 years at McKinsey & Company; 3 years as President & CEO of EndoStim; and 3 years as Emergency Service Officer for the National Safety Council of Australia

Serves on the Board of Nexstim, Helsinki, Finland

PhD in Physics from Harvard University and a BS (Hons), Physics from Monash University

Over three decades experience in medicine and medical affairs, research, clinical, healthcare insurance, and regulatory registration and approvals; with specialties that include Immunology and Allergy, Asthma, COPD, Cardiovascular Disease, Diabetes and Pediatrics

Former Instructor, Harvard Medical School; Medical Advisor, Asthma & Allergy Foundation of America

Career highlights include: Sr. Vice President, Global Medical Affairs, DBV Technologies; Executive Director, Health Science Executives / Head, Health Science Executives, Boehringer-Ingelheim; Vice President & National Practice Leader, Pulmonary and Immunology – Therapeutic Resource Centers, Medco Health Solutions; Executive Director, Medical Affairs, Mylan (Medical Affairs global responsibilities for the EpiPen auto-injector franchise); Executive Director, WorldWide Consumer Medicines, Bristol-Myers Squibb Company; Sr. Director, Consumer Health Care, Schering-Plough Corporation 

Widely published, including New England Journal of Medicine, Journal of Allergy and Clinical Immunology, Clinical Therapeutics, Immunology News, Medico Interamericano, and Annals of Allergy and Clinical Immunology. 

A global thought leader and product marketing expert in the areas of consumer products, global marketing, direct sales, technology, software, big data, and gamification

Helped mastermind the development and global launch of the Xbox 360; Armed with a $19 Billion budget he helped steer the Xbox franchise into one of most successful consumer product launches in history

Career highlights include executive leadership positions at Microsoft, Nintendo, Lucasfilm (Star Wars franchise), Spectrum Holobyte and currently President of Redmer Productions

Designed and/or oversaw the development of some of the most well-known franchises in the Games industry including; SimCity, Star Wars, Indiana Jones, Tetris, Ridge Racer, Pokémon, Flight Simulator, Age of Empires, Project Gotham Racing and Forza Motorsport, with a combined adoption totaling almost one Billion users

Worked in and oversaw operations in multiple countries on all four continents, including the US, Europe, Latin America, Japan, China, Australia, South Korea and Singapore

Participated in five significant exits, of which three were acquisitions and two were IPOs

Almost three decades experience with a rare combination of clinical, research, business and medical affairs experiences in both small and large biopharmaceutical industry settings, with specialties including in COPD, Asthma and IPF, CardioMetabolic Diseases, hypertension and bronchoconstrictive diseases, and cardiac physiology, pharmacology and pathology

A comprehensive understanding of healthcare systems and PhRMA code; Strong ability to interact with national and regional key opinion leaders (KOLs), academic investigators, individual healthcare providers, organized customer, payers and internal team members

Career highlights include: Medical Director, Field Group, Pfizer; Senior Medical Science Liaison, Sanofi Genzyme; Senior Medical Science Liaison, Mallinckrodt Pharmaceuticals; and Associate Director, Health Science Executive, Boehringer Ingelheim Pharmaceuticals

Bilingual: fluent in English and Mandarin